Skip to Main Content

Paper Details

A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells.
bioRxiv
7
2020
3CL cysteine protease, 4, A549/, A549/ACE2, ACE2, Caco-2, Caco-2 cells, Calu-3, Calu-3,, CoV-1, CoV-1 spike protein, HeLa, HeLa/ACE2, HeLa/ACE2 cells, K777, S1 domain, SARS, SARS-CoV-2, SARS-CoV-2 spike protein, Vero E6, Vero E6 cells, cathepsin B, cathepsin L, cathepsins, cysteine, host cathepsin L, host cells, human, human and monkey cells, mammalian cysteine proteases, monkey, papain-like cysteine protease, propargyl, spike protein, vinyl-sulfone, viral spike protein
Author NameAffiliation
Chien-Te K TsengUniversity of Texas, 3000 University Boulevard
Aaron F CarlinUniversity of California
Laura BerettaSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
Frank M RaushelTexas A&M University, College Station
Anthony J O'DonoghueSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
James H McKerrowSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego
  • 1 - 6

Datasets

Release 1.2